Literature DB >> 12357588

Ethical issues in oncology biostatistics.

Peter F Thall1.   

Abstract

A medical statistician's routine professional activities are likely to have important ethical consequences. This is due in part to the fact that good medical practice and scientifically valid medical research both require as precursors high quality statistical design and data analysis. In this paper I discuss various ethical issues that I have encountered while working as a biostatistician at M.D. Anderson Cancer Center. I describe particular experiences and the ethical issues involved. Topics include medical decision making, benefit-harm trade-offs, safety monitoring, adaptive randomization, informed consent, and publication bias.

Entities:  

Mesh:

Year:  2002        PMID: 12357588     DOI: 10.1191/0962280202sm301ra

Source DB:  PubMed          Journal:  Stat Methods Med Res        ISSN: 0962-2802            Impact factor:   3.021


  7 in total

Review 1.  An informatics blueprint for healthcare quality information systems.

Authors:  Joyce C Niland; Layla Rouse; Douglas C Stahl
Journal:  J Am Med Inform Assoc       Date:  2006-04-18       Impact factor: 4.497

2.  Ethical debate: the ethics of not performing extended lymphadenectomy in patients with gastrointestinal cancer.

Authors:  Alberto R Ferreres
Journal:  World J Surg       Date:  2013-08       Impact factor: 3.352

3.  Bayesian adaptive randomization designs for targeted agent development.

Authors:  J Jack Lee
Journal:  Clin Trials       Date:  2010-06-22       Impact factor: 2.486

4.  Worth adapting? Revisiting the usefulness of outcome-adaptive randomization.

Authors:  J Jack Lee; Nan Chen; Guosheng Yin
Journal:  Clin Cancer Res       Date:  2012-07-02       Impact factor: 12.531

5.  Bayesian Two-stage Biomarker-based Adaptive Design for Targeted Therapy Development.

Authors:  Xuemin Gu; Nan Chen; Caimiao Wei; Suyu Liu; Vassiliki A Papadimitrakopoulou; Roy S Herbst; J Jack Lee
Journal:  Stat Biosci       Date:  2014-12-04

6.  Bayesian adaptive design for targeted therapy development in lung cancer--a step toward personalized medicine.

Authors:  Xian Zhou; Suyu Liu; Edward S Kim; Roy S Herbst; J Jack Lee
Journal:  Clin Trials       Date:  2008       Impact factor: 2.486

Review 7.  Factors influencing the statistical planning, design, conduct, analysis and reporting of trials in health care: A systematic review.

Authors:  Marina Zaki; Lydia O'Sullivan; Declan Devane; Ricardo Segurado; Eilish McAuliffe
Journal:  Contemp Clin Trials Commun       Date:  2022-01-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.